Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

3 Pharma Stocks Flashing 'Buy' Signals in December

The pharmaceutical industry is well-positioned for robust growth, driven by growing healthcare expenditure globally and the rapid adoption of digital technologies. Given the industry’s tailwinds, fundamentally strong pharma stocks, Collegium Pharmaceutical (COLL), Eton Pharmaceuticals (ETON), and GSK plc (GSK) could be ideal buys this month. Continue Reading….

StockNews.com

Two babies infected with rare bacteria sometimes found in powdered infant formula

A Kentucky child is dead and a Missouri infant has brain damage from the same kind of bacteria that sparked powdered formula recalls and shortages last year

The Independent UK

3 Rising Pharma Stocks to Consider Buying Now

The pharmaceutical sector is transforming due to the swift uptake of digital solutions and worldwide spending growth. Hence, fundamentally strong pharma stocks Supernus Pharmaceuticals (SUPN), Astellas Pharma (ALPMY), and Eli Lilly (LLY) might be solid buys now. Read more….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Will Abortion Issues Return to the Supreme Court?

The Court has been asked to intervene in cases involving abortion pills and criminal prosecution of abortion doctors.

Reason

Vaccine for superbugs? New shot shows promise in early tests

A new vaccine, so far tested only in mice, broadly activates the immune system against a wide array of bacteria and fungi.

LiveScience

White House delays menthol cigarette ban, alarming anti-smoking advocates

The White House is pushing back a plan to ban menthol cigarettes, an unexpected delay that quickly sparked criticism from anti-smoking groups

The Independent UK

FDA delays menthol ban following lobbying war - Roll Call

In a victory for the tobacco industry, the Biden administration is delaying a proposed ban on menthol cigarettes and flavored cigars.

Roll Call

Read news from The Economist, FT, and more,
with one subscription

FDA is inspecting plant in Ecuador that made lead-tainted fruit pouches

U.S. health officials have launched an inspection of a plant in Ecuador that made the cinnamon applesauce pouches linked to dozens of cases of acute lead poisoning in U.S. children

The Independent UK

Analyzing December Profit Potential for the Top 4 Pharma Stocks

The global pharmaceutical market is witnessing robust growth, fueled by an escalating demand for healthcare services amid a burgeoning and aging population. Hence, fundamentally solid pharma stocks Novartis (NVS), Bristol-Myers Squibb (BMY), AbbVie (ABBV), and Taro Pharmaceutical (TARO) might be solid buys for gains this month. Read more.

StockNews.com

Which Weight Loss Drug Is Best And Safest? Here’s What Sets Them Apart

Earlier this month, the FDA approved Eli Lilly's Zepbound, a drug similar to its diabetes drug Mounjaro but specifically advertised for weight loss.

Inverse

This Small Cap Company is Revolutionizing Vascular Health

It’s no secret that the rate cycle, combined with an AI frenzy, greatly helped mega cap stocks this past year, and greatly harmed small cap stocks in need of capital. But, there may have been some throwing out the baby with the bath water activity in small caps that are…

StockNews.com

What is the state of RSV in the United States?

RSV rates — which tend to climb in the fall and winter months — are highest for children under the age of five.

USAFacts

Chasing Weight Loss Dream, Many In US Seek Ozempic Alternatives

Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called "wonder drugs" described as revolutionary in the fight against obesity.

International Business Times

FDA Approves Zepbound, the Latest Weight-Loss Drug: The Kiplinger Letter

Eli Lily’s Zepbound will undercut its rivals’ pricing but still costs over $1,000 a month.

Kiplinger

Get all your
news in one place.

100’s of premium titles.
One news app.

WEKU

What works for treating the common cold? Many doctors say 'not much'

One common decongestant, phenylephrine, was found ineffective this fall. Doctors are skeptical about the rest of the over-the-counter cold cures lineup.

Medical Daily

FDA Warns Of Potentially Life-Threatening Reaction To Seizure Medications; Know Signs Of Severe Side-Effects

Antiseizure drugs levetiracetam and clobazam can cause a serious hypersensitivity reaction called drug reactions with eosinophilia and systemic symptoms (DRESS), the FDA said.

International Business Times

Philips Stock Slumps After New FDA Warning

Shares in Dutch medical device manufacturer Philips plunged Wednesday after the US Food and Drug Administration warned that its new machine to help patients sleep risked overheating.

StockNews.com

3 Pharma Stocks on the Rise - It's Time to Buy Now

The pharma industry’s long-term solid outlook is driven by steady demand for drugs due to the rising frequency of chronic conditions and growing geriatric population coupled with rapid technological innovations. Hence, quality pharma stocks, CytomX Therapeutics (CTMX), Eton Pharmaceuticals (ETON), and GSK (GSK), might be solid investments now for potential…

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Markets Today: Stock Index Futures Slip on Weakness in European Stocks

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are down -0.17%, and Dec Nasdaq 100 E-Mini futures (NQZ2 3) are down -0.20%. Stock index futures this morning are under pressure on negative carryover from a decline in the Euro Stoxx 50 to a 1-week low. European stocks fell back...

The Hindu

Indian drug manufacturers benefit from Big Pharma interest beyond China

Drugmakers shift reliance from China to India, benefiting Indian CDMOs. Western pharma companies are seeking to limit reliance on Chinese contractors, leading to increased interest in Indian CDMOs.

Medical Daily

'Gas Station Heroin' Supplement Causes Seizures, Loss Of Consciousness, FDA Warns

Neptune's Fix, a product sold illegally with claims to improve brain function and treat conditions such as anxiety, depression, pain and opioid use disorder, contains a potentially dangerous substance called tianeptine.

The Guardian - UK

Dr Chelsea Polis: ‘The scientific world recognises when you stick your neck out and do the right thing’

The US reproductive health expert on being sued for $1m, and winning a top prize for her fight for free speech in the public interest

LiveScience

Science news this week: The Atlantic's missing blob and 100,000 ancient coins

Nov. 26, 2023: Our weekly roundup of the latest science in the news, as well as a few fascinating articles to keep you entertained over the weekend.

The Hindu

Reforms panel recommends rationalisation of clerical posts, revision of water tariff for industrial use, among other measures

KARC-2 recommends rationalising clerical posts, revising water tariff for industrial use, collecting slum improvement cess & more.

The Independent UK

Several more children sickened by fruit pouches tainted with lead, FDA says

U.S. health officials are reporting more cases of children sickened by fruit puree pouches that were recalled due to lead contamination

1 … 90 91 92 93

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.